Page last updated: 2024-10-22

tyrphostin ag 1024 and Colonic Neoplasms

tyrphostin ag 1024 has been researched along with Colonic Neoplasms in 1 studies

tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
" The data suggest that GLP-2 stimulates cancer myofibroblast proliferation, migration and invasion; GLP-2 acts indirectly on epithelial cells partly via increased IGF expression in myofibroblasts and partly, perhaps, by increased bioavailability through degradation of IGFBPs."1.46Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway. ( Dockray, GJ; Dodd, S; Giger, O; Holden, W; Kumar, JD; Shawe-Taylor, M; Varga, A; Varro, A, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shawe-Taylor, M1
Kumar, JD1
Holden, W1
Dodd, S1
Varga, A1
Giger, O1
Varro, A1
Dockray, GJ1

Other Studies

1 other study available for tyrphostin ag 1024 and Colonic Neoplasms

ArticleYear
Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway.
    Peptides, 2017, Volume: 91

    Topics: Aged, 80 and over; Cell Movement; Cell Proliferation; Coculture Techniques; Colonic Neoplasms; Cultu

2017